PACTR202302799565020尚未招募3 期
REDUCING MORTALITY IN ADULTS WITH ADVANCED HIV DISEASE (REVIVE)
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 8,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Age = 18 years
- •Documented HIV infection
- •CD4 count criteria:
- •CD4 count = 100 cells/mm3 within past 30 days if on ART; or
- •Documented CD4 nadir = 100 cells/mm3 and complete interruption of ART for = 6 months; or
- •Documented CD4 count = 100 cells/mm3 if ART-naive
- •Ability to initiate or re-initiate ART, or switch to an effective ART regimen if failing current therapy, within 2 weeks of enrolment
排除标准
- •Contraindications to azithromycin:
- •Hypersensitivity to azithromycin, erythromycin, or any macrolide antibiotic; or
- •Personal or family history of QT-prolongation
- •Severe illness requiring immediate or continued hospitalisation*
- •*This will be in the judgement of site investigators.
研究者
相似试验
已完成
不适用
Home care and routine: cryptococcal meningitis screening among patients starting antiretroviral therapy with advanced diseaseISRCTN20410413ondon School of Hygiene and Tropical Medicine (UK)2,500
招募中
3 期
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)HIV Disease ProgressionNCT05580666Population Health Research Institute8,000
招募中
不适用
Optimal Management of HIV-Infected Adults at Risk for Kidney Complications in Nigeria (R3 Study)Kidney DiseasePACTR201711002808414Vanderbilt University Medical Center280
已完成
不适用
Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor SettingsHIV InfectionNCT02921516Florida International University278
已完成
3 期
Reduction of early mortality in HIV-infected African adults and children starting antiretroviral therapyHuman Immunodeficiency Virus (HIV)Infections and InfestationsHuman immunodeficiency virus [HIV] diseaseISRCTN43622374Medical Research Council (UK)1,805